Dihexa 2mg — Vial Spec, Reconstitution Math & COA

Overview of the Dihexa 2mg Research Specification

The 2mg vial of Dihexa (N-hexanoic-Tyr-Ile-6-aminohexanoic amide, also identified as PNB-0408) is formulated specifically for benchtop investigators who require low mass unit sizing to conduct preliminary in-vitro screening, enzyme kinetics assays, or initial ligand-binding experiments. Providing 2mg of lyophilized cake per vial minimizes waste during pilot phases, enabling precise calculation of nanomolar and micromolar concentrations without subjecting excess compound to repeated reconstitution cycles.

Principal investigators and laboratory technicians frequently select 2mg fill sizes when testing cell culture viability across variable concentration gradients or when establishing baseline analytical methods via high-performance liquid chromatography (HPLC). If your laboratory requires alternate delivery media or larger assay volumes, PX1 Research maintains a range of formats across our catalog, including solid oral research specs such as Dihexa capsules 10mg for specific animal model administration research, as well as bulk raw powders for larger synthesis projects.

Chemical Structure, Solubility, and Molecular Characteristics

Dihexa is an oligopeptide derivative designed to bind with ultra-high affinity to Hepatocyte Growth Factor (HGF). Chemically synthesized with an N-terminal hexanoyl group and an amide-capped C-terminus, the molecule exhibits a molecular formula of C27H44N4O5 and a nominal molecular weight of approximately 504.66 g/mol.

In its lyophilized form, Dihexa appears as a white to off-white dense cake or powder. Due to the hydrophobic nature of its N-hexanoyl chain and isoleucine residue, solubility in pure aqueous diluents like sterile water or standard saline can be limited at higher concentrations. For complete dissolution, researchers typically utilize dimethyl sulfoxide (DMSO) as a primary stock solvent before diluting into aqueous buffers, or utilize sterile bacteriostatic water containing standard preservative matrices depending on assay requirements.

Reconstitution Math for 2mg Dihexa Vials

Accurate dilution calculations are critical for maintaining reproducible molar concentrations in cell-free or cell-based experimental models. Reconstitution math for a 2mg vial depends directly on the volume of diluent added to the vial:

1.0 mL Diluent Addition: Yields a final working concentration of 2.0 mg/mL (2000 µg/mL). In terms of molarity, this equates to approximately 3.96 mM solution. 2.0 mL Diluent Addition: Yields a final working concentration of 1.0 mg/mL (1000 µg/mL), corresponding to approximately 1.98 mM solution. 3.0 mL Diluent Addition: Yields a final working concentration of 0.667 mg/mL (667 µg/mL), corresponding to approximately 1.32 mM solution.

To rapidly calculate custom concentrations or microliter-to-microgram conversions for specific multi-well plate layouts, researchers should use the interactive reconstitution calculator tool prior to reconstituting lyophilized compounds.

Aliquot Planning, Diluent Protocols, and Reagent Conservation

Because reconstituted peptide bonds and hydrophobic side chains are subject to degradation and surface adsorption over time, establishing an efficient aliquot protocol immediately after fluid entry is paramount. Working solutions should be prepared under sterile laminar flow hoods using calibrated volumetric pipettes.

Once the 2mg cake is fully solubilized, the stock solution should be divided into single-use microcentrifuge tubes (e.g., 50 µL to 100 µL per aliquot) using low-binding polypropylene vials. This step prevents the degradation caused by multiple freeze-thaw cycles. Diluents containing 0.9% benzyl alcohol (bacteriostatic water) or dilute DMSO/PBS matrices should be selected based on the sensitivity of the downstream target culture or enzymatic assay.

Preclinical Mechanisms: HGF/c-Met Pathway and Synaptogenesis Assays

In preclinical literature, Dihexa is characterized as an orally active, lipophilic compound that binds to HGF with high affinity ($K_d \approx 10^{-12} \text{ M}$). In vitro binding assays demonstrate that Dihexa facilitates the dimerization of HGF, which subsequently triggers autophosphorylation of the c-Met receptor tyrosine kinase.

Animal studies and cultured neuronal preparations indicate that activation of the HGF/c-Met signaling cascade by Dihexa promotes spinogenesis and synaptogenesis. Researchers evaluating synaptic plasticity, dendritic arborization, and cognitive biomarkers measure localized c-Met phosphorylation levels and PSD-95 protein expression in response to varying concentrations of the compound.

Comparative Peptide Analysis: Dihexa vs. Other Nootropic Compounds

When evaluating compounds designed to modulate neuroplasticity, cognitive biomarkers, or synaptic architecture, researchers frequently compare Dihexa to other neuroactive research peptides. Each class acts through distinct receptor mechanisms:

While Dihexa targets the HGF/c-Met axis to induce structural synaptogenesis, synthetic ACTH analogs like Semax 5mg operate primarily by elevating Brain-Derived Neurotrophic Factor (BDNF) and modulating melanocortin receptor activity. Similarly, anxiolytic heptapeptides like Selank 5mg influence allosteric GABA-A receptor sites and enkephalin stability, while modified derivatives like Adamax 10mg combine BDNF upregulation with enhanced lipophilic cell-permeability. Exploring the complete catalog of research peptides allows laboratories to select the exact molecular pathway required for their specific comparative models.

Quality Assurance: Lot-Matched HPLC, MS, and COA Verification

Assay integrity relies on chemical purity and exact mass verification. PX1 Research enforces strict quality assurance protocols across every production batch. Every lot of Dihexa undergo rigorous analytical verification at an independent ISO 17025 accredited laboratory in the USA.

Analytical verification includes High-Performance Liquid Chromatography (HPLC) to confirm peptide purity exceeds 98.0%, Mass Spectrometry (MS) to verify precise molecular weight, and Chromogenic LAL assays to ensure endotoxin levels remain below strictly defined limits (< 0.01 EU/mg). Researchers can inspect, download, and archive verified test results directly through the public PX1 COA database.

Stability, Temperature Control, and Storage Protocols

Lyophilized Dihexa 2mg vials remain stable when stored under desiccated conditions at -20°C for up to 24 months. For long-term archival storage, temperature stability is maintained at -80°C. Protect the product from prolonged exposure to light and ambient moisture.

Following reconstitution, liquid stock solutions stored at 4°C should be used within 7 to 14 days depending on the diluent matrix used. Frozen aliquots (-20°C or -80°C) maintain stability for extended periods, though researchers must avoid repeated freeze-thaw cycles that induce physical degradation of the peptide structure.

Vial Selection Strategy: When 2mg is the Optimal Research Choice

Selecting the 2mg vial specification is ideal for research groups conducting preliminary feasibility studies, single-plate in-vitro assays, or short-term baseline characterization. By ordering smaller unit masses, laboratories prevent financial waste and eliminate the risk of product degradation associated with storing partially used reconstitutions.

For labs scaling up to high-throughput screening or multi-animal cohort studies, larger vial sizes or specialized formats may offer superior workflow efficiency. Detailed mechanism guides, primary data, and assay protocol suggestions are accessible directly within our research library hub. Institutional buyers preparing large-scale comparative studies can submit high-volume requirements via our wholesale lab account portal.